Export: +91 9820402906   Domestic: +91 7710003340 | HR: +91 9137757219

Vitamin B1, B2 & Niacinamide Tablets

Three-vitamin B-complex formulation for nutritional support, normal energy metabolism and maintenance of skin and mucosal health.

Product Overview

Composition: Thiamine Mononitrate (B1), Riboflavin (B2) and Niacinamide (B3).

Strengths: Multiple supplied options; a final per-tablet combination has not been confirmed.

Manufacturer named: Healthy Life Pharma Pvt. Ltd. Exporter named: Healthy Inc.

Enquiries: +91 7710003340

Categories

Product Information

Vitamin B1, B2 & Niacinamide Tablets is listed for pharmaceutical business-to-business enquiries. Exact active ingredients, formulation, strength, pack configuration and manufacturer details should be confirmed against the product label and approved technical documentation before ordering.

Description

1. Product Introduction

Vitamin B1, B2 & Niacinamide Tablets combine three water-soluble B vitamins involved in normal cellular energy metabolism and the maintenance of healthy skin and mucosal tissues. Thiamine supports carbohydrate metabolism and nervous-system function, while riboflavin and niacinamide support enzyme systems needed for normal tissue function.

This targeted nutritional supplement may be appropriate where dietary intake of these nutrients is insufficient or deficiency is established. Mouth sores and fatigue have many causes; this combination is not a universal cure for stomatitis or mouth ulcers.

Healthy Life Pharma Pvt. Ltd. is identified as the manufacturer and Healthy Inc as exporter in the supplied product brief. Contract manufacturing and export requirements should be confirmed directly.

2. Product Specifications

IngredientSupplied strength options
Vitamin B1 (Thiamine Mononitrate)2 mg / 5 mg / 10 mg
Vitamin B2 (Riboflavin)2 mg / 5 mg / 10 mg
Vitamin B3 (Niacinamide)20 mg / 25 mg / 50 mg

Dosage form options: Sugar-coated or film-coated tablets. Therapeutic category: Nutritional supplement.

Verification: Strengths are options, not a confirmed fixed formula. USP/BP/IP compliance, 24–36-month shelf life, coating color and 10×10/bulk packaging require approved product-specific documentation.

3. Manufacturing Technology

Formulation development may use validated blending, compression and protective coating processes. Thiamine mononitrate can be less hygroscopic than thiamine hydrochloride in some formulations; riboflavin requires attention to light exposure. Appropriate packaging should be chosen using stability evidence.

Specific use of direct compression, titanium dioxide, shellac or particular equipment is not confirmed for this product and should not be claimed without batch and formulation records.

4. Quality Assurance

  • Identity and assay of thiamine mononitrate, riboflavin and niacinamide using validated analytical methods.
  • Content uniformity, tablet weight, hardness, friability and disintegration as applicable.
  • Stability and packaging compatibility studies to justify storage conditions and expiry.
  • Microbial and impurity testing to the approved finished-product specification.

Numerical assay limits and disintegration times depend on the approved applicable standard; no universal 90–110% assay or 30/45-minute criterion is asserted here.

5. Nutritional Roles and Uses

  • Thiamine (B1): Supports normal energy metabolism and nervous-system function.
  • Riboflavin (B2): Contributes to normal energy metabolism and maintenance of skin and mucosal tissues.
  • Niacinamide (B3): Participates in NAD/NADP-dependent metabolic pathways and supports normal tissue function.

These vitamins may help correct their respective deficiencies. They do not restore gut flora after antibiotics and should not be promoted as an established treatment for recurrent aphthous ulcers without diagnosis.

6. Export and Regulatory Support

For international supply, buyers may request a certificate of analysis, product specification, stability summary, approved artwork, registration documents and relevant manufacturing authorization. Availability of CTD/ACTD dossiers, FSC, COPP and WHO-GMP certification must be verified before publication or quotation. Export arrangements are subject to the importing country's requirements.

7. Frequently Asked Questions

Q: Which vitamins are present?
A: B1 (Thiamine Mononitrate), B2 (Riboflavin) and B3 (Niacinamide) only.

Q: Why might urine become bright yellow?
A: Riboflavin can cause bright-yellow urine, which is usually harmless.

Q: Does this treat every mouth ulcer?
A: No. Vitamin deficiencies can contribute to some oral symptoms, but persistent or recurrent ulcers need medical evaluation.

Q: Is it suitable for children?
A: Suitability and dose depend on age and the exact tablet strength. Consult a pediatric clinician; do not crush coated tablets unless the product instructions permit it.

8. Dosage and Administration

Use the dose on the final approved product label or as prescribed by a qualified clinician. A single daily or therapeutic dose cannot be recommended for every combination of the listed strength options. Take with water; taking the tablet with food may reduce stomach upset. Children require age-appropriate products and medical guidance.

9. Side Effects and Precautions

  • Mild nausea or stomach discomfort may occur.
  • Riboflavin may cause bright-yellow urine.
  • Niacinamide is generally less likely to cause flushing than nicotinic acid; excessive niacinamide intake may cause adverse effects.
  • Check for allergies to coating colors or excipients and avoid unnecessarily combining multiple vitamin products.
  • Persistent mouth lesions, unexplained fatigue or suspected deficiency should be clinically evaluated.

10. Storage Instructions

Protect from light and moisture in the original, tightly closed packaging. The final temperature limit and shelf life must follow product-specific approved stability data; “below 25°C” and “24–36 months” are not independently verified. Keep out of reach of children.

For healthcare professional and B2B reference. Product availability, approvals, certifications, manufacturing processes, packaging and prescribing details must be verified for the relevant market.